Selective Inhibition of Interleukin-2 Inducible T Cell Kinase (ITK) Enhances Anti-Tumor Immunity in Association with Th1-skewing, Cytotoxic T cell Activation, and Reduced T Cell Exhaustion
Published in 2023 by
Lih-Yun Hsu,
James T. Rosenbaum 
,
Erik Verner,
William B. Jones,
Craig M. Hill,
James W. Janc,
Joseph J. Buggy,
Ning Ding,
John C. Reneau,
Michael S. Khodadoust,
Youn H. Kim,
Ryan A. Wilcox,
Richard A. Miller
,
Erik Verner,
William B. Jones,
Craig M. Hill,
James W. Janc,
Joseph J. Buggy,
Ning Ding,
John C. Reneau,
Michael S. Khodadoust,
Youn H. Kim,
Ryan A. Wilcox,
Richard A. Miller
